Quest Diagnostics Maintains Quarterly Dividend at $0.86 per Share

  • Quest Diagnostics declared a quarterly cash dividend of $0.86 per share.
  • Dividend is payable on July 22, 2026 to shareholders of record on July 8, 2026.
  • Company serves half of U.S. physicians and hospitals and one in three American adults annually.
  • Quest Diagnostics employs nearly 57,000 people globally.

Quest Diagnostics' consistent dividend payout reflects its stable cash flow and commitment to shareholder returns. As a leader in diagnostic information services, the company's ability to maintain this payout will be closely watched, especially in an environment where healthcare costs and regulatory pressures are evolving. The dividend declaration underscores the company's financial discipline and strategic focus on delivering diagnostic insights that drive better health outcomes.

Dividend Sustainability
Whether Quest Diagnostics can maintain this dividend level amid potential healthcare cost pressures.
Market Position
How the company's extensive reach among U.S. physicians and hospitals influences its financial stability.
Operational Efficiency
The pace at which Quest Diagnostics can deliver smarter, simpler testing solutions to drive profitability.